Literature DB >> 19282287

Ikaros stability and pericentromeric localization are regulated by protein phosphatase 1.

Marcela Popescu1, Zafer Gurel, Tapani Ronni, Chunhua Song, Ka Ying Hung, Kimberly J Payne, Sinisa Dovat.   

Abstract

Ikaros encodes a zinc finger protein that is involved in gene regulation and chromatin remodeling. The majority of Ikaros localizes at pericentromeric heterochromatin (PC-HC) where it regulates expression of target genes. Ikaros function is controlled by posttranslational modification. Phosphorylation of Ikaros by CK2 kinase determines its ability to bind DNA and exert cell cycle control as well as its subcellular localization. We report that Ikaros interacts with protein phosphatase 1 (PP1) via a conserved PP1 binding motif, RVXF, in the C-terminal end of the Ikaros protein. Point mutations of the RVXF motif abolish Ikaros-PP1 interaction and result in decreased DNA binding, an inability to localize to PC-HC, and rapid degradation of the Ikaros protein. The introduction of alanine mutations at CK2-phosphorylated residues increases the half-life of the PP1-nonbinding Ikaros mutant. This suggests that dephosphorylation of these sites by PP1 stabilizes the Ikaros protein and prevents its degradation. In the nucleus, Ikaros forms complexes with ubiquitin, providing evidence that Ikaros degradation involves the ubiquitin/proteasome pathway. In vivo, Ikaros can target PP1 to the nucleus, and a fraction of PP1 colocalizes with Ikaros at PC-HC. These data suggest a novel function for the Ikaros protein; that is, the targeting of PP1 to PC-HC and other chromatin structures. We propose a model whereby the function of Ikaros is controlled by the CK2 and PP1 pathways and that a balance between these two signal transduction pathways is essential for normal cellular function and for the prevention of malignant transformation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19282287      PMCID: PMC2679487          DOI: 10.1074/jbc.M900209200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  54 in total

1.  Ikaros DNA-binding proteins direct formation of chromatin remodeling complexes in lymphocytes.

Authors:  J Kim; S Sif; B Jones; A Jackson; J Koipally; E Heller; S Winandy; A Viel; A Sawyer; T Ikeda; R Kingston; K Georgopoulos
Journal:  Immunity       Date:  1999-03       Impact factor: 31.745

2.  Repression by Ikaros and Aiolos is mediated through histone deacetylase complexes.

Authors:  J Koipally; A Renold; J Kim; K Georgopoulos
Journal:  EMBO J       Date:  1999-06-01       Impact factor: 11.598

3.  Ikaros SUMOylation: switching out of repression.

Authors:  Pablo Gómez-del Arco; Joseph Koipally; Katia Georgopoulos
Journal:  Mol Cell Biol       Date:  2005-04       Impact factor: 4.272

4.  Ikaros sets thresholds for T cell activation and regulates chromosome propagation.

Authors:  N Avitahl; S Winandy; C Friedrich; B Jones; Y Ge; K Georgopoulos
Journal:  Immunity       Date:  1999-03       Impact factor: 31.745

5.  Leukemic HRX fusion proteins inhibit GADD34-induced apoptosis and associate with the GADD34 and hSNF5/INI1 proteins.

Authors:  H T Adler; R Chinery; D Y Wu; S J Kussick; J M Payne; A J Fornace; D C Tkachuk
Journal:  Mol Cell Biol       Date:  1999-10       Impact factor: 4.272

6.  Interactor-mediated nuclear translocation and retention of protein phosphatase-1.

Authors:  Bart Lesage; Monique Beullens; Mieke Nuytten; Aleyde Van Eynde; Stefaan Keppens; Bernard Himpens; Mathieu Bollen
Journal:  J Biol Chem       Date:  2004-10-22       Impact factor: 5.157

7.  Decreases in Ikaros activity correlate with blast crisis in patients with chronic myelogenous leukemia.

Authors:  H Nakayama; F Ishimaru; N Avitahl; N Sezaki; N Fujii; K Nakase; Y Ninomiya; A Harashima; J Minowada; J Tsuchiyama; K Imajoh; T Tsubota; S Fukuda; T Sezaki; K Kojima; M Hara; H Takimoto; S Yorimitsu; I Takahashi; A Miyata; S Taniguchi; Y Tokunaga; H Gondo; Y Niho; M Harada
Journal:  Cancer Res       Date:  1999-08-15       Impact factor: 12.701

8.  Antigen receptor signaling induces MAP kinase-mediated phosphorylation and degradation of the BCL-6 transcription factor.

Authors:  H Niu; B H Ye; R Dalla-Favera
Journal:  Genes Dev       Date:  1998-07-01       Impact factor: 11.361

9.  Differential subcellular localization of protein phosphatase-1 alpha, gamma1, and delta isoforms during both interphase and mitosis in mammalian cells.

Authors:  P R Andreassen; F B Lacroix; E Villa-Moruzzi; R L Margolis
Journal:  J Cell Biol       Date:  1998-06-01       Impact factor: 10.539

10.  Pre-T cell receptor (TCR) and TCR-controlled checkpoints in T cell differentiation are set by Ikaros.

Authors:  S Winandy; L Wu; J H Wang; K Georgopoulos
Journal:  J Exp Med       Date:  1999-10-18       Impact factor: 14.307

View more
  51 in total

Review 1.  Ikaros, CK2 kinase, and the road to leukemia.

Authors:  Sinisa Dovat; Chunhua Song; Kimberly J Payne; Zhanjun Li
Journal:  Mol Cell Biochem       Date:  2011-07-13       Impact factor: 3.396

2.  Zinc finger structure-function in Ikaros Marvin A Payne.

Authors:  Marvin A Payne
Journal:  World J Biol Chem       Date:  2011-06-26

3.  Ikaros in B cell development and function.

Authors:  Maclean Sellars; Philippe Kastner; Susan Chan
Journal:  World J Biol Chem       Date:  2011-06-26

4.  Transcription factor Ikaros represses protein phosphatase 2A (PP2A) expression through an intronic binding site.

Authors:  Kamalpreet Nagpal; Katsue Sunahori Watanabe; Betty P Tsao; George C Tsokos
Journal:  J Biol Chem       Date:  2014-04-01       Impact factor: 5.157

Review 5.  Casein Kinase II (CK2), Glycogen Synthase Kinase-3 (GSK-3) and Ikaros mediated regulation of leukemia.

Authors:  Chandrika Gowda; Mario Soliman; Malika Kapadia; Yali Ding; Kimberly Payne; Sinisa Dovat
Journal:  Adv Biol Regul       Date:  2017-06-13

Review 6.  Regulation of cellular proliferation in acute lymphoblastic leukemia by Casein Kinase II (CK2) and Ikaros.

Authors:  Chandrika Gowda; Chunhua Song; Malika Kapadia; Jonathon L Payne; Tommy Hu; Yali Ding; Sinisa Dovat
Journal:  Adv Biol Regul       Date:  2016-09-18

7.  Conserved residues in the N terminus of lipin-1 are required for binding to protein phosphatase-1c, nuclear translocation, and phosphatidate phosphatase activity.

Authors:  Bernard P C Kok; Tamara D Skene-Arnold; Ji Ling; Matthew G K Benesch; Jay Dewald; Thurl E Harris; Charles F B Holmes; David N Brindley
Journal:  J Biol Chem       Date:  2014-02-20       Impact factor: 5.157

8.  Transcriptional Regulation of JARID1B/KDM5B Histone Demethylase by Ikaros, Histone Deacetylase 1 (HDAC1), and Casein Kinase 2 (CK2) in B-cell Acute Lymphoblastic Leukemia.

Authors:  Haijun Wang; Chunhua Song; Yali Ding; Xiaokang Pan; Zheng Ge; Bi-Hua Tan; Chandrika Gowda; Mansi Sachdev; Sunil Muthusami; Hongsheng Ouyang; Liangxue Lai; Olivia L Francis; Christopher L Morris; Hisham Abdel-Azim; Glenn Dorsam; Meixian Xiang; Kimberly J Payne; Sinisa Dovat
Journal:  J Biol Chem       Date:  2015-12-10       Impact factor: 5.157

9.  Serine phosphorylation by SYK is critical for nuclear localization and transcription factor function of Ikaros.

Authors:  Fatih M Uckun; Hong Ma; Jian Zhang; Zahide Ozer; Sinisa Dovat; Cheney Mao; Rita Ishkhanian; Patricia Goodman; Sanjive Qazi
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-15       Impact factor: 11.205

10.  Protein phosphatase 1 abrogates IRF7-mediated type I IFN response in antiviral immunity.

Authors:  Ling Wang; Juan Zhao; Junping Ren; Kenton H Hall; Jonathan P Moorman; Zhi Q Yao; Shunbin Ning
Journal:  Eur J Immunol       Date:  2016-08-29       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.